<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:video="http://www.google.com/schemas/sitemap-video/1.1">
  <url>
    <loc>https://synerkinepharma.com/latest-news</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2024-09-10</lastmod>
  </url>
  <url>
    <loc>https://synerkinepharma.com/latest-news/ny112yx452xtt6apzb81dxdjc4p1pn</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2024-09-11</lastmod>
  </url>
  <url>
    <loc>https://synerkinepharma.com/latest-news/synerkine-pharma-and-northx-biologics-sign-manufacturing-alliance</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2024-02-19</lastmod>
  </url>
  <url>
    <loc>https://synerkinepharma.com/latest-news/synerkine-pharma-appoints-industry-veteran-anders-ekblom-to-its-board-of-directors</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2024-02-19</lastmod>
  </url>
  <url>
    <loc>https://synerkinepharma.com/latest-news/synerkine-pharma-secures-eur-121-million-to-accelerate-novel-pain-therapeutics-towards-clinical-proof-of-concept</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2024-01-25</lastmod>
  </url>
  <url>
    <loc>https://synerkinepharma.com/latest-news/new-members-to-advisory-board</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2023-10-12</lastmod>
  </url>
  <url>
    <loc>https://synerkinepharma.com/latest-news/emilie-rodrigues-joins-synerkine-pharma</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2022-02-02</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/60586b57a5940469575828a5/0c22733a-eb4c-4483-826e-bfc7d7f0d035/ER+2.jpg</image:loc>
      <image:title>Latest news - Emilie Rodrigues joins Synerkine Pharma - Make it stand out</image:title>
      <image:caption>Whatever it is, the way you tell your story online can make all the difference.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://synerkinepharma.com/latest-news/synerkine-pharma-announces-series-a-extension</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2023-10-12</lastmod>
  </url>
  <url>
    <loc>https://synerkinepharma.com/latest-news/2020/10/tki-toekenning</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2023-10-10</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/60586b57a5940469575828a5/1616423757089-89GJWN90C57RWD5G1BMM/Synerkine-Contact-header.jpg</image:loc>
      <image:title>Latest news - Synerkine collaboration partner receives LSH-TKI grant</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://synerkinepharma.com/prseriesa</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-12-15</lastmod>
  </url>
  <url>
    <loc>https://synerkinepharma.com/synerkines</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2023-10-11</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/60586b57a5940469575828a5/1617875092522-FRC5IDQBMISFKRFUR0BO/MoA_graphic.jpg</image:loc>
      <image:title>Synerkines</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://synerkinepharma.com/about</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2024-09-11</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/60586b57a5940469575828a5/1618217640176-ZAGGFX5PIXMZPWNFZ3F5/Logo.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://synerkinepharma.com/pipeline</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2024-09-11</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/60586b57a5940469575828a5/d5812f00-b84b-4457-aa67-e403a5d7410a/Synerkine_Pipeline.png</image:loc>
      <image:title>Pipeline</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/60586b57a5940469575828a5/26e9f8dc-a3bc-4ead-ba35-cf13f30b3672/Synerkine_Pipeline_Programs.png</image:loc>
      <image:title>Pipeline</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://synerkinepharma.com/theo</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2023-10-10</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/60586b57a5940469575828a5/1616420750596-3ISBHIKAHUI2ORLKY75B/team-theo.jpg</image:loc>
      <image:title>Theo</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://synerkinepharma.com/press-releases</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2024-09-11</lastmod>
  </url>
  <url>
    <loc>https://synerkinepharma.com/home</loc>
    <changefreq>daily</changefreq>
    <priority>1.0</priority>
    <lastmod>2023-10-10</lastmod>
  </url>
  <url>
    <loc>https://synerkinepharma.com/the-story</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-03-25</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/60586b57a5940469575828a5/1616411408538-IP64DQJ1S6J8C4TGFZ67/Synerkine%2BAbout%2Bheader.jpg</image:loc>
      <image:title>The story</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://synerkinepharma.com/hans</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2024-02-18</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/60586b57a5940469575828a5/1616420732225-LHG6F0BULKBB26OOL2QP/team-hans.jpg</image:loc>
      <image:title>Hans</image:title>
      <image:caption>Tobias Keene, D.D.S. Hailing from Richmond, Virginia, Dr. Tobias Keene brings a bit of unabashed Southern hospitality to all his patients. He moved to Washington, D.C. over thirty years ago as a freshman at Ivy College. Right after graduation, he attended World University’s School of Dentistry. Before opening Keene Dental in 1994, he worked for free clinics and some of the finest practices in the District. He is part of the 123 Dental Association and stays up-to-date on the latest dental discoveries. When not striving to keep his patients happy and healthy, he’s enjoys hiking with his family in Rock Creek Park.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://synerkinepharma.com/investors</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-05-08</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/60586b57a5940469575828a5/1616427628788-73I1P5FXEFLEW00UW0IC/UH_logo_fc_tagline-01.png</image:loc>
      <image:title>Investors - UTRECHT HOLDINGS</image:title>
      <image:caption>Utrecht Holdings is the Knowledge Transfer Office (KTO) of Utrecht University and University Medical Center Utrecht. We are focused on the utilization and commercialization of academic research. We support scientists in creating, building, and investing in innovations with a particular expertise in biotech, medtech, education and ICT.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/60586b57a5940469575828a5/037e3ba9-4571-43a8-8834-4898abafd7e4/UtrechtHealthSeedFund_Logo.png</image:loc>
      <image:title>Investors - Utrecht Health Seed Fund</image:title>
      <image:caption>Utrecht Health Seed Fund (UHSF) is an early-stage life sciences &amp; health investment fund based out of Utrecht, The Netherlands, focused on scalable technologies in the field of Life Sciences (therapeutics and diagnostics), Medical Devices, Digital Health, and Animal Health, in the earliest stages of development. UHSF is established by Utrecht Holdings with the assistance and support of the European Regional Development Fund (ERDF), UMC Utrecht, and the University of Utrecht.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://synerkinepharma.com/key-publications</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-04-08</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/60586b57a5940469575828a5/1616660014581-TM805O3E45R3JGD4S4Z0/key+publications.jpeg</image:loc>
      <image:title>Key publications</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://synerkinepharma.com/pressrelease20211216</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-12-15</lastmod>
  </url>
  <url>
    <loc>https://synerkinepharma.com/emilie</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2023-10-10</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/60586b57a5940469575828a5/1563dbb0-555f-42dd-8c1c-07ce00cb1da5/ER+2.jpg</image:loc>
      <image:title>Emilie</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://synerkinepharma.com/pressrelease20211216-1</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2024-02-18</lastmod>
  </url>
  <url>
    <loc>https://synerkinepharma.com/pressrelease20240125</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2024-02-18</lastmod>
  </url>
  <url>
    <loc>https://synerkinepharma.com/pressrelease20240219</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2024-02-18</lastmod>
  </url>
  <url>
    <loc>https://synerkinepharma.com/pressrelease20240911</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2024-09-10</lastmod>
  </url>
  <url>
    <loc>https://synerkinepharma.com/team-1</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2026-11-11</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/60586b57a5940469575828a5/1616420732225-LHG6F0BULKBB26OOL2QP/team-hans.jpg</image:loc>
      <image:title>Team (Copy)</image:title>
      <image:caption>Tobias Keene, D.D.S. Hailing from Richmond, Virginia, Dr. Tobias Keene brings a bit of unabashed Southern hospitality to all his patients. He moved to Washington, D.C. over thirty years ago as a freshman at Ivy College. Right after graduation, he attended World University’s School of Dentistry. Before opening Keene Dental in 1994, he worked for free clinics and some of the finest practices in the District. He is part of the 123 Dental Association and stays up-to-date on the latest dental discoveries. When not striving to keep his patients happy and healthy, he’s enjoys hiking with his family in Rock Creek Park.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/60586b57a5940469575828a5/1616420750596-3ISBHIKAHUI2ORLKY75B/team-theo.jpg</image:loc>
      <image:title>Team (Copy)</image:title>
      <image:caption>THEO DINKLO, PHD VP, R&amp;D</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/60586b57a5940469575828a5/7e89c0ff-8aa3-47a3-9a6f-8be174a73bed/Emilie+SKP.jpg</image:loc>
      <image:title>Team (Copy)</image:title>
      <image:caption>Emilie Rodrigues, PhD Director CMC Development</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://synerkinepharma.com/advisory-board-1</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://synerkinepharma.com/board-1</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://synerkinepharma.com/get-started</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2023-09-29</lastmod>
  </url>
  <url>
    <loc>https://synerkinepharma.com/get-started/p/relationship-with-youothers-ng5zk</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2026-08-27</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5ced8e1d5fd4c700018dd761/1560190004400-XTA0DF0S9WOZJUG994C8/Stocksy_txp824ffa5crXt000_Original_845035.jpg</image:loc>
      <image:title>Get Started - Relationship with You+Others</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://synerkinepharma.com/get-started/p/relationship-with-others-2298x</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2026-08-27</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5ced8e1d5fd4c700018dd761/1560189982811-KFAJF1TCUH1SXZ827UMC/Stocksy_txp824ffa5crXt000_Large_844923.jpg</image:loc>
      <image:title>Get Started - Relationship with Others</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://synerkinepharma.com/get-started/p/relationship-with-you-75snl</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2026-08-27</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/5ced8e1d5fd4c700018dd761/1560189874730-3B0TSLDUHTQ93497V3L8/Stocksy_txp824ffa5crXt000_Large_844934A.jpg</image:loc>
      <image:title>Get Started - Relationship with You</image:title>
    </image:image>
  </url>
</urlset>

